BindingDB logo
myBDB logout

39 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28523109 79 Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4.EBI Glaxosmithkline
27964995 42 Synthesis and optimization of novela-phenylglycinamides as selective TRPM8 antagonists.EBI Kissei Pharmaceutical
26235950 41 Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.EBI Renovis
25893043 36 Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain.EBI Pfizer
25455494 172 Effect of acyclic monoterpene alcohols and their derivatives on TRP channels.EBI Sapienza University of Rome
25455182 52 Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.EBI Raqualia Pharma
24884675 70 Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.EBI Genomics Institute of The Novartis Research Foundation
24597733 57 Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists.EBI Amgen
24080460 24 Serendipity in drug-discovery: a new series of 2-(benzyloxy)benzamides as TRPM8 antagonists.EBI Pfizer
24055075 42 Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.EBI Glenmark Pharmaceuticals
23121096 86 Ion channels as therapeutic targets: a drug discovery perspective.EBI Pfizer
21128593 44 Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.EBI Janssen Pharmaceutica
20570528 34 Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists.EBI Abbott Laboratories
20356305 151 Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.EBI Ferrara University
22330635 25 Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.EBI Janssen Pharmaceutica
21634377 73 Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.EBI Amgen
20965726 20 5-benzyloxytryptamine as an antagonist of TRPM8.EBI Renovis
17293875 3 TRPM8 voltage sensor mutants reveal a mechanism for integrating thermal and chemical stimuli.EBI Ku Leuven
32787109 45 Exploration of TRPM8 Binding Sites by ?-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities.EBI University of Salerno
30507122 4 Onydecalins, Fungal Polyketides with Anti- Histoplasma and Anti-TRP Activity.EBI University of Utah
30500190 36 Design and Optimization of Sulfone Pyrrolidine Sulfonamide Antagonists of Transient Receptor Potential Vanilloid-4 with in Vivo Activity in a Pulmonary Edema Model.EBI TBA
30878828 109 N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.EBI University of Hull
29939028 17 Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity.EBI University of Salerno
30148953 75 Discovery of TRPM8 Antagonist ( S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine.EBI TBA
30335378 25 Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4).EBI TBA
29723786 9 Design, synthesis and biological activities of 2,3-dihydroquinazolin-4(1H)-one derivatives as TRPM2 inhibitors.EBI Peking University
28740604 22 Identification of a Novel TRPM8 Agonist from Nutmeg: A Promising Cooling Compound.EBI Kao
28662813 80 Discovery and development of a novel class of phenoxyacetyl amides as highly potent TRPM8 agonists for use as cooling agents.EBI Senomyx
29590749 24 Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling.EBI Pharmaron-Beijing